Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Testing effectiveness (Phase 2)Looking for participantsNCT03667170What this trial is testingKN035 for dMMR/MSI-H Advanced Solid TumorsWho this might be right forSolid Tumor 3D Medicines (Sichuan) Co., Ltd. 200
Testing effectiveness (Phase 2)UnknownNCT04411524What this trial is testingThe Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal CancerWho this might be right forLocally Advanced Rectal Cancer Fudan University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+7 more Udai Kammula 20
Testing effectiveness (Phase 2)WithdrawnNCT04001101What this trial is testingAnti-PD-1 +/- RT for MSI-H Solid TumorsWho this might be right forMicrosatellite Instability HighMismatch Repair DeficiencyColorectal Cancer University of Colorado, Denver
Testing effectiveness (Phase 2)Active Not RecruitingNCT07523763What this trial is testingNeoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal CancerWho this might be right forColorectal Cancer (MSI-H)Colorectal Cancer (CRC) Blokhin's Russian Cancer Research Center 30
Testing effectiveness (Phase 2)UnknownNCT04118933What this trial is testingPD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal CancerWho this might be right forColorectal Cancer Xu jianmin 40
Not applicableStudy completedNCT03774862What this trial is testingClinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort StudyWho this might be right forColorectal Medullary Carcinoma V.K.V. American Hospital, Istanbul 13
Not applicableUnknownNCT00232960What this trial is testingPostoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCCWho this might be right forOral CancerOropharynx Cancer Gustave Roussy, Cancer Campus, Grand Paris 310
Testing effectiveness (Phase 2)Looking for participantsNCT04114136What this trial is testingAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesWho this might be right forMelanomaNSCLCHepatocellular Carcinoma+5 more Dan Zandberg 72
Early research (Phase 1)Ended earlyNCT05909995What this trial is testingInterventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsWho this might be right forMelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more Incyte Corporation 8
Not applicableUnknownNCT04191226What this trial is testingGenetic Mutation in Recurrent Cervical CancerWho this might be right forRecurrent Cervical CancerNucleotide VariantCopy Number Variation+6 more Lei Li 300
Testing effectiveness (Phase 2)Looking for participantsNCT06002789What this trial is testingSafety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCCWho this might be right forMultiple CancerColorectal Cancer Sixth Affiliated Hospital, Sun Yat-sen University 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05890742What this trial is testingA Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon CancerWho this might be right forMSI-H Innovent Biologics (Suzhou) Co. Ltd. 453
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Who this might be right forAdvanced CancerAnal CarcinomaAnal Cancer+22 more Merck Sharp & Dohme LLC 1,609
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228What this trial is testingTesting the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyWho this might be right forMetastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7 National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Looking for participantsNCT06686576What this trial is testingNeoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon CancerWho this might be right forColon Cancer Qilu Pharmaceutical Co., Ltd. 363
Not applicableStudy completedNCT05162248What this trial is testingMicrosatellite Instability in Colorectal CancersWho this might be right forColorectal CancerColorectal CarcinomaMicrosatellite Instability High+2 more Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 231
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527What this trial is testingEvaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)Who this might be right forNeoplasms, Endometrial GlaxoSmithKline 100